The Right COAs Could Change Clinical Trial Outcomes in Alzheimer’s Disease

Fill out the form to access this whitepaper on how COAs can change clinical trial outcomes in Alzheimer's disease.

First Name

Last Name

Country

Organization type

Company

Role

Role Detail

If other

I would like to receive e-mails with special offers, product information, and event notifications. You can unsubscribe at any time. Please view our privacy policy here.

Yes!

The Right COAs Could Change Clinical Trial Outcomes in Alzheimer’s Disease

ASSESSMENTS

CLINICAL LEGAL POLICIES

HELP & SUPPORT

ABOUT PEARSON